Arch Venture Management’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.6M | Hold |
|
|||||
|
2025
Q1 | $9.12M | Hold |
|
|||||
|
2024
Q4 | $11.3M | Hold |
|
|||||
|
2024
Q3 | $9.72M | Hold |
|
|||||
|
2024
Q2 | $9.8M | Hold |
|
|||||
|
2024
Q1 | $26.7M | Hold |
|
|||||
|
2023
Q4 | $28M | Hold |
|
|||||
|
2023
Q3 | $26.6M | Hold |
|
|||||
|
2023
Q2 | $37.7M | Hold |
|
|||||
|
2023
Q1 | $29M | Hold |
|
|||||
|
2022
Q4 | $38.9M | Hold |
|
|||||
|
2022
Q3 | $69M | Sell |
|
|||||
|
2022
Q2 | $38.3M | Hold |
|
|||||
|
2022
Q1 | $57.3M | Hold |
|
|||||
|
2021
Q4 | $92.5M | Buy |
|